For purposes of this chapter, the following terms have the following definitions: (a) âDEHPâ means Di(2-ethylhexyl) phthalate. (b) âIntentionally added DEHPâ means DEHP that a manufacturer has intentionally added to an intravenous solution container or intravenous tubing product that has a functional or technical effect on the product. (c) âIntravenous solution containersâ means a container used to house medicine, fluid, or nutrition therapy that is intravenously administered to patients in a hospital, outpatient, or other health care facility. (d) âIntravenous tubingâ means any tubing used to intravenously administer fluids, medication, or nutrients directly to an adult, child, or infant. (e) âOrtho-phthalatesâ means a class of chemicals that are esters of ortho-phthalic acid, including all of the following: (1) Benzyl-butyl phthalate (BBP) 85-68-7. (2) Dibutyl phthalate (DBP) 84-74-2. (3) Dicyclohexyl phthalate (DCHP) 84-61-7. (4) Di-(2-ethylhexyl) phthalate (DEHP) 117-81-7. (5) Diethyl phthalate (DEP) 84-66-2. (6) Di-isobutyl phthalate (DIBP) 84-69-5. (7) Di-isodecyl phthalate (DIDP) 26761-40-0. (8) Di-isononyl phthalate (DINP) 28553-12-0. (9) Di-n-hexyl phthalate (DnHP) 84-75-3. (10) Di-n-octyl phthalate (DNOP) 117-84-0. (11) Di-n-pentyl (DnPP) phthalate 131-18-0. (12) Diisoheptyl phthalate (DIHP) 71888-89-6. (f) âUnintentionally added DEHPâ means DEHP in an intravenous solution container or intravenous tubing product that is not used for functional or technical effect on the product.
‹ Prev All California sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.